|
1
|
Linares MA, Zakaria A and Nizran P: Skin
Cancer. Prim Care. 42:645–659. 2024.
|
|
2
|
Verdaguer-Faja J, Toll A, Boada A,
Guerra-Amor Á, Ferrándiz-Pulido C and Jaka A: Management of
cutaneous squamous cell carcinoma of the scalp: The role of imaging
and therapeutic approaches. Cancers (Basel). 16(664)2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Howell JY and Ramsey ML: Squamous Cell
Skin Cancer. 2023 Jul 31. In: StatPearls (Internet). StatPearls
Publishing, Treasure Island, FL, 2024.
|
|
4
|
Jansen P, Lodde GC, Griewank KG, Hadaschik
E, Roesch A, Ugurel S, Zimmer L, Livingstone E and Schadendorf D:
Management of partial and non-responding cutaneous squamous cell
carcinoma. J Eur Acad Dermatol Venereol. 36 (Suppl 1):S29–S34.
2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yuan S, Zhu T, Wang J, Jiang R, Shu A,
Zhang Z, Zhang P, Feng X and Zhao L: miR-22 promotes
immunosuppression via activating JAK/STAT3 signaling in cutaneous
squamous cell carcinoma. Carcinogenesis. 44:549–561.
2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kumah E and Bibee K: Modelling cutaneous
squamous cell carcinoma for laboratory research. Exp Dermatol.
32:117–125. 2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kyriazi M, Yova D, Rallis M and Lima A:
Cancer chemopreventive effects of Pinus Maritima bark extract on
ultraviolet radiation and ultraviolet
radiation-7,12,dimethylbenz(a)anthracene induced skin
carcinogenesis of hairless mice. Cancer Lett. 237:234–241.
2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Robinson K and Tiriveedhi V: Perplexing
role of P-glycoprotein in tumor microenvironment. Front Oncol.
10(265)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang B, Liu M, Tang HK, Ma HB, Wang C,
Chen X and Huang HZ: The expression and significance of MRP1, LRP,
TOPOIIβ, and BCL2 in tongue squamous cell carcinoma. J Oral Pathol
Med. 41:141–148. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lu JF, Pokharel D and Bebawy M: MRP1 and
its role in anticancer drug resistance. Drug Metab Rev. 47:406–419.
2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sahin TK, Ayasun R, Rizzo A and Guven DC:
Prognostic value of neutrophil-to-eosinophil ratio (NER) in cancer:
A systematic review and meta-analysis. Cancers (Basel).
16(3689)2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Guven DC, Erul E, Kaygusuz Y, Akagunduz B,
Kilickap S, De Luca R and Rizzo A: Immune checkpoint
inhibitor-related hearing loss: A systematic review and analysis of
individual patient data. Support Care Cancer.
31(624)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rizzo A, Mollica V, Marchetti A, Nuvola G,
Rosellini M, Tassinari E, Molina-Cerrillo J, Myint ZW, Buchler T,
Monteiro FSM, et al: Adjuvant PD-1 and PD-L1 inhibitors and
relapse-free survival in cancer patients: The MOUSEION-04 study.
Cancers (Basel). 14(4142)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mollica V, Rizzo A, Marchetti A, Tateo V,
Tassinari E, Rosellini M, Massafra R, Santoni M and Massari F: The
impact of ECOG performance status on efficacy of immunotherapy and
immune-based combinations in cancer patients: The MOUSEION-06
study. Clin Exp Med. 23:5039–5049. 2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Guven DC, Sahin TK, Erul E, Rizzo A, Ricci
AD, Aksoy S and Yalcin S: The association between albumin levels
and survival in patients treated with immune checkpoint inhibitors:
A systematic review and meta-analysis. Front Mol Biosci.
9(1039121)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Aboul-Fettouh N, Morse D, Patel J and
Migden MR: Immunotherapy and systemic treatment of cutaneous
squamous cell carcinoma. Dermatol Pract Concept. 11 (Suppl
2)(e2021169S)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Spadafora M, Paganelli A, Raucci M, Kaleci
S, Peris K, Guida S, Pellacani G and Longo C: Neoadjuvant
immunotherapy in cutaneous squamous cell carcinoma: Systematic
literature review and state of the art. Cancers.
17(637)2025.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Abdou AG, Eldien MM and Elsakka D: GLUT-1
expression in cutaneous basal and squamous cell carcinomas. Int J
Surg Pathol. 23:447–453. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang Y and Wang J: Targeting uptake
transporters for cancer imaging and treatment. Acta Pharm Sin B.
10:79–90. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kunkel M, Moergel M, Stockinger M, Jeong
JH, Fritz G, Lehr HA and Whiteside TL: Overexpression of GLUT-1 is
associated with resistance to radiotherapy and adverse prognosis in
squamous cell carcinoma of the oral cavity. Oral Oncol. 43:796–803.
2007.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Meyer HJ, Wienke A and Surov A:
Associations between GLUT expression and SUV values derived from
FDG-PET in different tumors-A systematic review and meta analysis.
PLoS One. 14(e0217781)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li F, He C, Yao H, Liang W, Ye X, Ruan J,
Lin L, Zou J, Zhou S, Huang Y, et al: GLUT1 regulates the tumor
immune microenvironment and promotes tumor metastasis in pancreatic
adenocarcinoma via ncRNA-mediated Network. J Cancer. 13:2540–2558.
2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ancey PB, Contat C, Boivin G, Sabatino S,
Pascual J, Zangger N, Perentes JY, Peters S, Abel ED, Kirsch DG, et
al: GLUT1 expression in tumor-associated neutrophils promotes lung
cancer growth and resistance to radiotherapy. Cancer Res.
81:2345–2357. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Harshani JM, Yeluri S and Guttikonda VR:
Glut-1 as a prognostic biomarker in oral squamous cell carcinoma. J
Oral Maxillofac Pathol. 18:372–378. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Eckert AW, Lautner MH, Taubert H, Schubert
J and Bilkenroth U: Expression of Glut-1 is a prognostic marker for
oral squamous cell carcinoma patients. Oncol Rep. 20:1381–1385.
2008.PubMed/NCBI
|
|
26
|
Kelley DJ, Pavelic ZP, Gapany M, Stambrook
P, Pavelic L, Gapany S and Gluckman JL: Detection of P-glycoprotein
in squamous cell carcinomas of the head and neck. Arch Otolaryngol
Head Neck Surg. 119:411–414. 1993.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Aloia TA, Harpole DH Jr, Reed CE, Allegra
C, Moore MB, Herndon JE II and D'Amico TA: Tumor marker expression
is predictive of survival in patients with esophageal cancer. Ann
Thorac Surg. 72:859–866. 2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Gallagher CH, Canfield PJ, Greenoak GE and
Reeve VE: Characterization and histogenesis of tumors in the
hairless mouse produced by low-dosage incremental ultraviolet
radiation. J Invest Dermatol. 83:169–174. 1984.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang S, Cao W, Yue M, Zheng N, Hu T, Yang
S, Dong Z, Lu S and Mo S: Caveolin-1 affects tumor drug resistance
in esophageal squamous cell carcinoma by regulating expressions of
P-gp and MRP1. Tumour Biol. 37:9189–9196. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pérez-Sayáns M, Somoza-Martín JM,
Barros-Angueira F, Diz PG, Rey JM and García-García A: Multidrug
resistance in oral squamous cell carcinoma: The role of vacuolar
ATPases. Cancer Lett. 295:135–143. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Trock BJ, Leonessa F and Clarke R:
Multidrug resistance in breast cancer: A meta-analysis of
MDR1/gp170 expression and its possible functional significance. J
Natl Cancer Inst. 89:917–931. 1997.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Dean M, Hamon Y and Chimini G: The human
ATP-binding cassette (ABC) transporter superfamily. J Lipid Res.
42:1007–1017. 2001.PubMed/NCBI
|
|
33
|
Ferini G, Palmisciano P, Forte S, Viola A,
Martorana E, Parisi S, Valenti V, Fichera C, Umana GE and
Pergolizzi S: Advanced or metastatic cutaneous squamous cell
carcinoma: The current and future role of radiation therapy in the
era of immunotherapy. Cancers (Basel). 14(1871)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Worley B, Harikumar V, Reynolds K, Dirr
MA, Christensen RE, Anvery N, Yi MD, Poon E and Alam M: Treatment
of actinic keratosis: A systematic review. Arch Dermatol Res.
315:1099–1108. 2023.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Greif CS, Srivastava D and Nijhawan RI:
Janus kinase inhibitors and non-melanoma skin cancer. Curr Treat
Options Oncol. 22(11)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Binderup T, Knigge UP, Federspiel B,
Sommer P, Hasselby JP, Loft A and Kjaer A: Gene expression of
glucose transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in
Gastroenteropancreatic neuroendocrine tumors: Correlation with
F-18-fluorodeoxyglucose positron emission tomography and cellular
proliferation. Diagnostics (Basel). 3:372–384. 2013.PubMed/NCBI View Article : Google Scholar
|
